ledipasvir

Ukraine

Drugs containing this active substance

  • KYRLED-LP

    The drug is intended for the treatment of adult patients with chronic hepatitis C (CHC).

    Form: tablets, film-coated

    Active substance Dosage
    ledipasvir 90 mg
    sofosbuvir 400 mg

    ATC: J05AP51

    Manufacturer: Strides Pharma Science Limited

  • The drug is intended for the treatment of chronic hepatitis C in adults and children aged 12 to 18 years.

    Form: tablets, film-coated

    Active substance Dosage
    ledipasvir 90 mg
    sofosbuvir 400 mg

    ATC: J05AP51

    Manufacturer: Hetero Labs Limited

  • It is indicated for the treatment of adult patients with chronic hepatitis C (CHC).

    Form: tablets, film-coated

    Active substance Dosage
    ledipasvir 90 mg
    sofosbuvir 400 mg

    ATC: J05AP51

    Manufacturer: Strides Pharma Science Limited